IMPAX Laboratories, Inc. (IPXL) Signs Distribution Agreements With Leiner Health Products Inc. For Loratadine Products
10/19/2005 5:08:59 PM
IMPAX Laboratories, Inc. (NASDAQ:IPXL) announced that it has signed a series of agreements with Leiner Health Products, LLC for the supply and distribution of the Company's Loratadine Orally Disintegrating Tablets (ODT) and Loratadine and Pseudoephedrine Sulfate Extended Release Tablets 24 hour products. Both of these products are indicated for the relief of symptoms of seasonal allergic rhinitis (hay fever). These products will be manufactured by IMPAX and marketed by Leiner as over the counter (OTC) store brand equivalents to both Claritin(R) Reditabs(R) and Claritin-D(R) 24-hour respectively.
comments powered by